Theranostic liposomes as a bimodal carrier for magnetic resonance imaging contrast agent and photosensitizer

Journal of Inorganic Biochemistry

Volumn 180, Issue , 2018, Pages 1-14

  Skupin Mrugalska, Paulina ^a   Sobotta, Lukasz ^a   Warowicka, Alicja ^b   Wereszczynska, Beata ^b   Zalewski, Tomasz ^b   Gierlich, Piotr ^a   Jarek, Marcin ^b   Nowaczyk, Grzegorz ^b   Kempka, Marek ^b   Gapinski, Jacek ^b   Jurga, Stefan ^b   Mielcarek, Jadwiga ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b ADAM MICKIEWICZ UNIVERSITY   (Poland)

Author keywords

Liposomes; Magnetic resonance imaging; Photodynamic therapy; Phthalocyanines; Theranostic

Indexed keywords

GADOLINIUM CHELATE; LIPOSOME; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; PENTETIC ACID; PHOTOSENSITIZING AGENT; PHTHALOCYANINE ZINC; SINGLET OXYGEN; CONTRAST MEDIUM; DRUG CARRIER; GADOLINIUM PENTETATE; INDOLE DERIVATIVE; ORGANOMETALLIC COMPOUND; ZN(II)-PHTHALOCYANINE;

ARTICLE; CALORIMETRY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ELECTROPHILICITY; FIBROBLAST; HELA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID BILAYER; LIPID COMPOSITION; LIPOSOME MEMBRANE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PHOTODYNAMIC THERAPY; PHOTODYNAMICS; PHYSICAL CHEMISTRY; QUANTUM YIELD; STEREOSPECIFICITY; SURFACE PROPERTY; TEMPERATURE; THERANOSTIC NANOMEDICINE; CELL CULTURE; CYTOLOGY; DIFFERENTIAL SCANNING CALORIMETRY; METABOLISM; PHOTOCHEMOTHERAPY; PROCEDURES; QUANTUM THEORY; TRANSMISSION ELECTRON MICROSCOPY;

CALORIMETRY, DIFFERENTIAL SCANNING; CELLS, CULTURED; CONTRAST MEDIA; DRUG CARRIERS; FIBROBLASTS; GADOLINIUM DTPA; HELA CELLS; HUMANS; INDOLES; LIPOSOMES; MAGNETIC RESONANCE IMAGING; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; ORGANOMETALLIC COMPOUNDS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; QUANTUM THEORY; SINGLET OXYGEN; THERANOSTIC NANOMEDICINE;

EID: 85037644099     PISSN: 01620134     EISSN: 18733344     Source Type: Journal    
DOI: 10.1016/j.jinorgbio.2017.11.025     Document Type: Article

References (59)

1. Sharman, W.M., Allen, C.M., van Lier, J.E., Photodynamic therapeutics: basic principles and clinical applications. Drug Discov. Today 4 (1999), 507–517, 10.1016/S1359-6446(99)01412-9.
2. Celli, J.P., Spring, B.Q., Rizvi, I., Evans, C.L., Samkoe, K.S., Verma, S., Pogue, B.W., Hasan, T., Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem. Rev. 110 (2010), 2795–2838, 10.1021/cr900300p.
3. Agostinis, P., Berg, K., Cengel, K.A., Foster, T.H., Girotti, A.W., Gollnick, S.O., Hahn, S.M., Hamblin, M.R., Juzeniene, A., Kessel, D., Korbelik, M., Moan, J., Mroz, P., Nowis, D., Piette, J., Wilson, B.C., Golab, J., Photodynamic therapy of cancer: an update. CA Cancer J. Clin. 61 (2011), 250–281, 10.3322/caac.20114.
4. Foote, C.S., Mechanisms of photosensitized oxidation. Science 162 (1968), 963–970, 10.1126/science.162.3857.963.
5. Dougherty, T.J., Gomer, C.J., Henderson, B.W., Jori, G., Kessel, D., Korbelik, M., Moan, J., Peng, Q., Photodynamic therapy. J. Natl. Cancer Inst. 90 (1998), 889–905.
6. Allison, R.R., Moghissi, K., Oncologic photodynamic therapy: clinical strategies that modulate mechanisms of action. Photodiagn. Photodyn. Ther. 10 (2013), 331–341, 10.1016/j.pdpdt.2013.03.011.
7. Schmidt-Erfurth, U., Hasan, T., Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. Surv. Ophthalmol. 45 (2000), 195–214, 10.1016/S0039-6257(00)00158-2.
8. Bushberg, J.T., Seibert, J.A., Jr, E.M.L., Boone, J.M., The Essential Physics of Medical Imaging. Third Edition, 2011, LWW, Philadelphia Third, North American Edition edition.
9. Strijkers, G.J., Mulder, W.J.M., van Tilborg, G.A.F., Nicolay, K., MRI contrast agents: current status and future perspectives. Anti Cancer Agents Med. Chem. 7 (2007), 291–305.
10. Erdogan, S., Torchilin, V.P., Gadolinium-loaded polychelating polymer-containing tumor-targeted liposomes. Weissig, V., (eds.) Liposomes, 2010, Humana Press, Totowa, NJ, 321–334.
11. Caride, V.J., Sostman, H.D., Winchell, R.J., Gore, J.C., Relaxation enhancement using liposomes carrying paramagnetic species. Magn. Reson. Imaging 2 (1984), 107–112, 10.1016/0730-725X(84)90064-X.
12. Gløgård, C., Stensrud, G., Hovland, R., Fossheim, S.L., Klaveness, J., Liposomes as carriers of amphiphilic gadolinium chelates: the effect of membrane composition on incorporation efficacy and in vitro relaxivity. Int. J. Pharm. 233 (2002), 131–140, 10.1016/S0378-5173(01)00935-8.
13. Torres, E., Mainini, F., Napolitano, R., Fedeli, F., Cavalli, R., Aime, S., Terreno, E., Improved paramagnetic liposomes for MRI visualization of pH triggered release. J. Control. Release 154 (2011), 196–202, 10.1016/j.jconrel.2011.05.017.
14. 2O)]. Biochim. Biophys. Acta Biomembr. 1838 (2014), 2807–2816, 10.1016/j.bbamem.2014.07.019.
15. Mulder, W.J.M., Strijkers, G.J., van Tilborg, G.A.F., Griffioen, A.W., Nicolay, K., Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR Biomed. 19 (2006), 142–164, 10.1002/nbm.1011.
16. Tilcock, C., Unger, E., Cullis, P., MacDougall, P., Liposomal Gd-DTPA: preparation and characterization of relaxivity. Radiology 171 (1989), 77–80, 10.1148/radiology.171.1.2928549.
17. Koenig, S.H., Ahkong, Q.F., Brown, R.D., Lafleur, M., Spiller, M., Unger, E., Tilcock, C., Permeability of liposomal membranes to water: results from the magnetic field dependence of T1 of solvent protons in suspensions of vesicles with entrapped paramagnetic ions. Magn. Reson. Med. 23 (1992), 275–286, 10.1002/mrm.1910230208.
18. Kopelman, R., Lee Koo, Y.-E., Philbert, M., Moffat, B.A., Ramachandra Reddy, G., McConville, P., Hall, D.E., Chenevert, T.L., Bhojani, M.S., Buck, S.M., Rehemtulla, A., Ross, B.D., Multifunctional nanoparticle platforms for in vivo MRI enhancement and photodynamic therapy of a rat brain cancer. J. Magn. Magn. Mater. 293 (2005), 404–410, 10.1016/j.jmmm.2005.02.061.
19. Benachour, H., Sève, A., Bastogne, T., Frochot, C., Vanderesse, R., Jasniewski, J., Miladi, I., Billotey, C., Tillement, O., Lux, F., Barberi-Heyob, M., Multifunctional peptide-conjugated hybrid silica nanoparticles for photodynamic therapy and MRI. Theranostics. 2 (2012), 889–904, 10.7150/thno.4754.
20. Zeng, L., Luo, L., Pan, Y., Luo, S., Lu, G., Wu, A., In vivo targeted magnetic resonance imaging and visualized photodynamic therapy in deep-tissue cancers using folic acid-functionalized superparamagnetic-upconversion nanocomposites. Nano 7 (2015), 8946–8954, 10.1039/C5NR01932J.
21. Peng, P.-C., Hong, R.-L., Tsai, Y.-J., Li, P.-T., Tsai, T., Chen, C.-T., Dual-effect liposomes encapsulated with doxorubicin and chlorin e6 augment the therapeutic effect of tumor treatment. Lasers Surg. Med. 47 (2015), 77–87, 10.1002/lsm.22312.
22. Tan, X., Pang, X., Lei, M., Ma, M., Guo, F., Wang, J., Yu, M., Tan, F., Li, N., An efficient dual-loaded multifunctional nanocarrier for combined photothermal and photodynamic therapy based on copper sulfide and chlorin e6. Int. J. Pharm. 503 (2016), 220–228, 10.1016/j.ijpharm.2016.03.019.
23. Feng, L., Cheng, L., Dong, Z., Tao, D., Barnhart, T.E., Cai, W., Chen, M., Liu, Z., Theranostic liposomes with hypoxia-activated prodrug to effectively destruct hypoxic tumors post-photodynamic therapy. ACS Nano 11 (2017), 927–937, 10.1021/acsnano.6b07525.
24. Li, S., Goins, B., Zhang, L., Bao, A., Novel multifunctional theranostic liposome drug delivery system: construction, characterization, and multimodality MR, near-infrared fluorescent, and nuclear imaging. Bioconjug. Chem. 23 (2012), 1322–1332, 10.1021/bc300175d.
25. Jung, S., Na, K., Lee, S.A., Cho, S., Seong, H., Shin, B., Gd(III)-DOTA-modified sonosensitive liposomes for ultrasound-triggered release and MR imaging. Nanoscale Res. Lett., 7, 2012, 462, 10.1186/1556-276X-7-462.
26. Rizzitelli, S., Giustetto, P., Cutrin, J.C., Delli Castelli, D., Boffa, C., Ruzza, M., Menchise, V., Molinari, F., Aime, S., Terreno, E., Sonosensitive theranostic liposomes for preclinical in vivo MRI-guided visualization of doxorubicin release stimulated by pulsed low intensity non-focused ultrasound. J. Control. Release 202 (2015), 21–30, 10.1016/j.jconrel.2015.01.028.
27. Düzgüneş N., Preparation and quantitation of small unilamellar liposomes and large unilamellar reverse-phase evaporation liposomes. Düzgüneş Nejat, (eds.) Methods in Enzymology, 367, 2003, Academic Press, 23–27.
28. Kucinska, M., Skupin-Mrugalska, P., Szczolko, W., Sobotta, L., Sciepura, M., Tykarska, E., Wierzchowski, M., Teubert, A., Fedoruk-Wyszomirska, A., Wyszko, E., Gdaniec, M., Kaczmarek, M., Goslinski, T., Mielcarek, J., Murias, M., Phthalocyanine derivatives possessing 2-(morpholin-4-yl)ethoxy groups as potential agents for photodynamic therapy. J. Med. Chem. 58 (2015), 2240–2255, 10.1021/acs.jmedchem.5b00052.
29. Sobotta, L., Fita, P., Szczolko, W., Wrotynski, M., Wierzchowski, M., Goslinski, T., Mielcarek, J., Functional singlet oxygen generators based on porphyrazines with peripheral 2,5-dimethylpyrrol-1-yl and dimethylamino groups. J. Photochem. Photobiol. A Chem. 269 (2013), 9–16, 10.1016/j.jphotochem.2013.06.018.
30. Hao, D., Ai, T., Goerner, F., Hu, X., Runge, V.M., Tweedle, M., MRI contrast agents: basic chemistry and safety. J. Magn. Reson. Imaging 36 (2012), 1060–1071, 10.1002/jmri.23725.
31. Sherry, A.D., Caravan, P., Lenkinski, R.E., Primer on gadolinium chemistry. J. Magn. Reson. Imaging 30 (2009), 1240–1248, 10.1002/jmri.21966.
32. Rohrer, M., Bauer, H., Mintorovitch, J., Requardt, M., Weinmann, H.-J., Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Investig. Radiol. 40 (2005), 715–724.
33. Sercombe, L., Veerati, T., Moheimani, F., Wu, S.Y., Sood, A.K., Hua, S., Advances and challenges of liposome assisted drug delivery. Front. Pharmacol., 6, 2015, 10.3389/fphar.2015.00286.
34. Wright, M., Nanoparticle tracking analysis for the multiparameter characterization and counting of nanoparticle suspensions. Methods Mol. Biol. Clifton NJ. 906 (2012), 511–524, 10.1007/978-1-61779-953-2_41.
35. Gebremedhin, S., Singh, A., Koons, S., Bernt, W., Konopka, K., Duzgunes, N., Gene delivery to carcinoma cells via novel non-viral vectors: nanoparticle tracking analysis and suicide gene therapy. Eur. J. Pharm. Sci. 60 (2014), 72–79, 10.1016/j.ejps.2014.03.003.
36. Soema, P.C., Willems, G.-J., Jiskoot, W., Amorij, J.-P., Kersten, G.F., Predicting the influence of liposomal lipid composition on liposome size, zeta potential and liposome-induced dendritic cell maturation using a design of experiments approach. Eur. J. Pharm. Biopharm. 94 (2015), 427–435, 10.1016/j.ejpb.2015.06.026.
37. McElhaney, R.N., The use of differential scanning calorimetry and differential thermal analysis in studies of model and biological membranes. Chem. Phys. Lipids 30 (1982), 229–259, 10.1016/0009-3084(82)90053-6.
38. Kuntsche, J., Freisleben, I., Steiniger, F., Fahr, A., Temoporfin-loaded liposomes: physicochemical characterization. Eur. J. Pharm. Sci. 40 (2010), 305–315, 10.1016/j.ejps.2010.04.005.
39. Campbell, R.B., Balasubramanian, S.V., Straubinger, R.M., Phospholipid-cationic lipid interactions: influences on membrane and vesicle properties. Biochim. Biophys. Acta 1512 (2001), 27–39, 10.1016/S0005-2736(01)00290-5.
40. Pili, B., Reddy, L.H., Bourgaux, C., Lepêtre-Mouelhi, S., Desmaële, D., Couvreur, P., Liposomal squalenoyl-gemcitabine: formulation, characterization and anticancer activity evaluation. Nano, 2, 2010, 1521, 10.1039/c0nr00132e.
41. Wei, T., Zheng, B., Yi, H., Gao, Y., Guo, W., Thermal analysis and non-isothermal kinetics of poly(ethylene glycol) with different molecular weight. Polym. Eng. Sci. 54 (2014), 2872–2876, 10.1002/pen.23846.
42. Kuznetsova, N.A., Kaliya, O.L., Oxidative photobleaching of phthalocyanines in solution. J. Porphyrins Phthalocyanines 16 (2012), 705–712, 10.1142/S1088424612300042.
43. Kuznetsova, N.A., Gretsova, N.S., Derkacheva, V.M., Kaliya, O.L., Lukyanets, E.A., Sulfonated phthalocyanines: aggregation and singlet oxygen quantum yield in aqueous solutions. J. Porphyrins Phthalocyanines 7 (2003), 147–154, 10.1142/S1088424603000203.
44. Valduga, G., Nonell, S., Reddi, E., Jori, G., Braslavsky, S.E., The production of singlet molecular oxygen by zinc(II) phthalocyanine in ethanol and in unilamellar vesicles. Chemical quenching and phosphorescence studies. Photochem. Photobiol. 48 (1988), 1–5.
45. Lauffer, R.B., Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem. Rev. 87 (1987), 901–927, 10.1021/cr00081a003.
46. Mornet, S., Vasseur, S., Grasset, F., Duguet, E., Magnetic nanoparticle design for medical diagnosis and therapy. J. Mater. Chem., 14, 2004, 2161, 10.1039/b402025a.
47. Gupta, A., Willis, S.A., Waddington, L.J., Stait-Gardner, T., de Campo, L., Hwang, D.W., Kirby, N., Price, W.S., Moghaddam, M.J., Gd-DTPA-dopamine-bisphytanyl amphiphile: synthesis, characterisation and relaxation parameters of the nanoassemblies and their potential as MRI contrast agents. Chem. Eur. J. 21 (2015), 13950–13960, 10.1002/chem.201501905.
48. Tilcock, C., Ahkong, Q.F., Koenig, S.H., Brown, R.D., Davis, M., Kabalka, G., The design of liposomal paramagnetic mr agents: effect of vesicle size upon the relaxivity of surface-incorporated lipophilic chelates. Magn. Reson. Med. 27 (1992), 44–51, 10.1002/mrm.1910270106.
49. Reichenbach, J.R., Hackländer, T., Harth, T., Hofer, M., Rassek, M., Mödder, U., 1H T1 and T2 measurements of the MR imaging contrast agents Gd-DTPA and Gd-DTPA BMA at 1.5T. Eur. Radiol. 7 (1997), 264–274, 10.1007/s003300050149.
50. Trubetskoy, V.S., Cannillo, J.A., Milshtein, A., Wolf, G.L., Torchilin, V.P., Controlled delivery of Gd-containing liposomes to lymph nodes: surface modification may enhance MRI contrast properties. Magn. Reson. Imaging 13 (1995), 31–37, 10.1016/0730-725X(94)00083-F.
51. Rodríguez, E., Roig, A., Molins, E., Arús, C., Quintero, M.R., Cabañas, M.E., Cerdán, S., Lopez-Larrubia, P., Sanfeliu, C., In vitro characterization of an Fe8 cluster as potential MRI contrast agent. NMR Biomed. 18 (2005), 300–307, 10.1002/nbm.959.
52. Lucas, R.L., Benjamin, M., Reineke, T.M., Comparison of a tartaric acid derived polymeric MRI contrast agent to a small molecule model chelate. Bioconjug. Chem. 19 (2008), 24–27, 10.1021/bc700375m.
53. Strijkers, G.J., Mulder, W.J.M., van Heeswijk, R.B., Frederik, P.M., Bomans, P., Magusin, P.C.M.M., Nicolay, K., Relaxivity of liposomal paramagnetic MRI contrast agents. Magn. Reson. Mater. Phys. Biol. Med. 18 (2005), 186–192, 10.1007/s10334-005-0111-y.
54. Jokerst, J.V., Lobovkina, T., Zare, R.N., Gambhir, S.S., Nanoparticle PEGylation for imaging and therapy. Nanomedicine 6 (2011), 715–728, 10.2217/nnm.11.19.
55. Torchilin, V.P., Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 4 (2005), 145–160, 10.1038/nrd1632.
56. Ngoune, R., Peters, A., von Elverfeldt, D., Winkler, K., Pütz, G., Accumulating nanoparticles by EPR: a route of no return. J. Control. Release 238 (2016), 58–70, 10.1016/j.jconrel.2016.07.028.
57. Bulbake, U., Doppalapudi, S., Kommineni, N., Khan, W., Liposomal formulations in clinical use: an updated review. Pharmaceutics., 9, 2017, 12, 10.3390/pharmaceutics9020012.
58. Fabris, C., Valduga, G., Miotto, G., Borsetto, L., Jori, G., Garbisa, S., Reddi, E., Photosensitization with zinc (II) phthalocyanine as a switch in the decision between apoptosis and necrosis. Cancer Res. 61 (2001), 7495–7500.
59. Cañete, M., Stockert, J.C., Villanueva, A., Preclinical photodynamic therapy research in Spain 3: localization of photosensitizers and mechanisms of cell death in vitro. J. Porphyrins Phthalocyanines 13 (2009), 544–551, 10.1142/S1088424609000516.